General OA media and info, page-96

Was a good video, nice to hear his take on a bit more of the MOA. A few errors such as 40% reduction in Australian Joint replacements?
That's definitely false as it is not approved in Australia for human joint replacements. Perhaps it was a stat from the vet industry?


Good on him for remaining independent though , as he also mentions, it one day may take away a fair chunk of business from the surgeons. Also another good point on insurance. If we manage to get it covered, and there are high chances we will as we plough through our main trial and importantly our associated trials like 006, 009 etc which add credence to durability, rescue medication and retreatment effects, which are all label broadening, this will be a very important and eventually lucrative point.

Get insurance coverage with the majority of the some 900 plus insurers in the USA and it will be a big boost to our overall future revenue profile.

Then add DMOAD potential.





My thoughts